Composition
- Active ingredients
- HALOBETASOL PROPIONATE 0.01%; TAZAROTENE 0.045%
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA217190.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Halobetasol Propionate and Tazarotene
- Active substance
- halobetasol propionate
- Route
- Topical
- Dosage form
- Lotion
- Applicant
- Sun Pharma Canada
- Status
- Prescription
- FDA approval
- 2 May 2025
- Application
- ANDA217190-001